Rizwan Hamer

838 total citations
22 papers, 449 citations indexed

About

Rizwan Hamer is a scholar working on Transplantation, Nephrology and Immunology. According to data from OpenAlex, Rizwan Hamer has authored 22 papers receiving a total of 449 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Transplantation, 7 papers in Nephrology and 7 papers in Immunology. Recurrent topics in Rizwan Hamer's work include Renal Transplantation Outcomes and Treatments (15 papers), Complement system in diseases (5 papers) and Renal Diseases and Glomerulopathies (5 papers). Rizwan Hamer is often cited by papers focused on Renal Transplantation Outcomes and Treatments (15 papers), Complement system in diseases (5 papers) and Renal Diseases and Glomerulopathies (5 papers). Rizwan Hamer collaborates with scholars based in United Kingdom, Nigeria and United States. Rizwan Hamer's co-authors include William McKane, Albert Ong, Daniel Zehnder, David Briggs, Rob Higgins, Simon Fletcher, Habib Kashi, For Tai Lam, David Lowe and Lam Chin Tan and has published in prestigious journals such as PLoS ONE, Transplantation and Nephrology Dialysis Transplantation.

In The Last Decade

Rizwan Hamer

22 papers receiving 446 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Rizwan Hamer United Kingdom 10 320 180 119 107 64 22 449
Koji Nanmoku Japan 12 183 0.6× 135 0.8× 115 1.0× 27 0.3× 84 1.3× 40 402
T. Frouget France 9 290 0.9× 193 1.1× 73 0.6× 44 0.4× 51 0.8× 16 434
Liesbeth Daniëls Belgium 10 344 1.1× 231 1.3× 94 0.8× 80 0.7× 51 0.8× 17 436
Michael Cecka United States 13 453 1.4× 333 1.9× 74 0.6× 67 0.6× 210 3.3× 27 656
Maïté Jaureguy France 10 141 0.4× 70 0.4× 83 0.7× 26 0.2× 35 0.5× 22 404
Elisabeth Dittrich Austria 9 157 0.5× 109 0.6× 130 1.1× 45 0.4× 35 0.5× 12 385
Masaki Muramatsu Japan 11 195 0.6× 134 0.7× 104 0.9× 27 0.3× 99 1.5× 61 357
Diana Carretero Spain 7 111 0.3× 123 0.7× 287 2.4× 29 0.3× 53 0.8× 8 428
Sabrina Louie United States 6 197 0.6× 120 0.7× 50 0.4× 105 1.0× 35 0.5× 7 288
É. Thervet France 7 268 0.8× 175 1.0× 44 0.4× 15 0.1× 69 1.1× 18 406

Countries citing papers authored by Rizwan Hamer

Since Specialization
Citations

This map shows the geographic impact of Rizwan Hamer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rizwan Hamer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rizwan Hamer more than expected).

Fields of papers citing papers by Rizwan Hamer

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Rizwan Hamer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rizwan Hamer. The network helps show where Rizwan Hamer may publish in the future.

Co-authorship network of co-authors of Rizwan Hamer

This figure shows the co-authorship network connecting the top 25 collaborators of Rizwan Hamer. A scholar is included among the top collaborators of Rizwan Hamer based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Rizwan Hamer. Rizwan Hamer is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Ng, Khai Ping, Meenu Sandhu, Dipanjan Banerjee, et al.. (2025). Fabry disease in the haemodialysis population: outcome of a UK screening study (SoFAH). BMC Nephrology. 26(1). 259–259. 1 indexed citations
2.
3.
Hamer, Rizwan, et al.. (2023). Do we practice what we preach? Dialysis modality choice among healthcare workers in the United Kingdom. Seminars in Dialysis. 36(5). 407–413. 2 indexed citations
4.
Hamer, Rizwan, et al.. (2021). Effects of fasting on solid organ transplant recipients during Ramadan – a practical guide for healthcare professionals. Clinical Medicine. 21(5). e492–e498. 6 indexed citations
5.
Hamer, Rizwan, et al.. (2021). Effects of fasting on patients with chronic kidney disease during Ramadan and practical guidance for healthcare professionals. Clinical Kidney Journal. 14(6). 1524–1534. 27 indexed citations
6.
Hamer, Rizwan, et al.. (2020). Prevalence, indication and duration of proton pump inhibitor use in patients from unselected admissions. Clinical Medicine. 20(2). s29–s29. 1 indexed citations
7.
Banham, Gemma D., Davide Prezzi, Craig J. Taylor, et al.. (2013). Elevated Pretransplantation Soluble BAFF Is Associated With an Increased Risk of Acute Antibody-Mediated Rejection. Transplantation. 96(4). 413–420. 59 indexed citations
8.
Krishnan, Nithya, Daniel Zehnder, Sunil Daga, et al.. (2013). Behaviour of Non-Donor Specific Antibodies during Rapid Re-Synthesis of Donor Specific HLA Antibodies after Antibody Incompatible Renal Transplantation. PLoS ONE. 8(7). e68663–e68663. 4 indexed citations
9.
Hamer, Rizwan, Guerman Molostvov, David Lowe, et al.. (2012). Human Leukocyte Antigen-Specific Antibodies and Gamma-Interferon Stimulate Human Microvascular and Glomerular Endothelial Cells to Produce Complement Factor C4. Transplantation. 93(9). 867–873. 16 indexed citations
10.
Lambie, Mark, Nithya Krishnan, Rizwan Hamer, et al.. (2011). Cryofiltration in the Treatment of Cryoglobulinemia and HLA Antibody‐Incompatible Transplantation. Therapeutic Apheresis and Dialysis. 16(1). 91–96. 9 indexed citations
11.
Hamer, Rizwan, Nithya Krishnan, David Lowe, et al.. (2011). C5b-9 inhibitor (eculizumab) for antibody-mediated rejection in renal transplantation. Indian Journal of Transplantation. 5(1). 6–8. 3 indexed citations
12.
Higgins, Robert, David Lowe, Mark Hathaway, et al.. (2011). Human Leukocyte Antigen Antibody-Incompatible Renal Transplantation: Excellent Medium-Term Outcomes With Negative Cytotoxic Crossmatch. Transplantation. 92(8). 900–906. 53 indexed citations
13.
Hamer, Rizwan, Laura Roche, David Smillie, et al.. (2010). Soluble CD30 and Cd27 levels in patients undergoing HLA antibody-incompatible renal transplantation. Transplant Immunology. 23(4). 161–165. 7 indexed citations
14.
Higgins, Rob, David Lowe, Mark Hathaway, et al.. (2010). Double Filtration Plasmapheresis in Antibody‐Incompatible Kidney Transplantation. Therapeutic Apheresis and Dialysis. 14(4). 392–399. 35 indexed citations
15.
Higgins, Rob, David Lowe, Mark Hathaway, et al.. (2009). Rises and Falls in Donor-Specific and Third-Party HLA Antibody Levels After Antibody Incompatible Transplantation. Transplantation. 87(6). 882–888. 32 indexed citations
16.
Higgins, Robert, Daniel Zehnder, Ken Chen, et al.. (2009). The histological development of acute antibody-mediated rejection in HLA antibody-incompatible renal transplantation. Nephrology Dialysis Transplantation. 25(4). 1306–1312. 11 indexed citations
17.
Krishnan, Nithya, Robert Higgins, Mark Hathaway, et al.. (2008). Application of Flow Cytometry to Monitor Antibody Levels in ABO Incompatible Kidney Transplantation. Transplantation. 86(3). 474–477. 27 indexed citations
18.
Higgins, Rob, Mark Hathaway, David Lowe, et al.. (2008). NEW CHOICES FOR PATIENTS NEEDING KIDNEY TRANSPLANTATION ACROSS ANTIBODY BARRIERS. Journal of Renal Care. 34(2). 85–93. 7 indexed citations
19.
Hamer, Rizwan, et al.. (2007). Polycystic Kidney Disease Is a Risk Factor for New-Onset Diabetes After Transplantation. Transplantation. 83(1). 36–40. 84 indexed citations
20.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Koji Nanmoku Breakdown of academic impact, for papers by T. Frouget Breakdown of academic impact, for papers by Liesbeth Daniëls Breakdown of academic impact, for papers by Michael Cecka Breakdown of academic impact, for papers by Maïté Jaureguy Breakdown of academic impact, for papers by Elisabeth Dittrich Breakdown of academic impact, for papers by Masaki Muramatsu Breakdown of academic impact, for papers by Diana Carretero Breakdown of academic impact, for papers by Sabrina Louie Breakdown of academic impact, for papers by É. Thervet
Rankless by CCL
2026